» Articles » PMID: 29196708

The Serine Proteinase Hepsin is an Activator of Pro-matrix Metalloproteinases: Molecular Mechanisms and Implications for Extracellular Matrix Turnover

Abstract

Increasing evidence implicates serine proteinases in the proteolytic cascades leading to the pathological destruction of extracellular matrices such as cartilage in osteoarthritis (OA). We have previously demonstrated that the type II transmembrane serine proteinase (TTSP) matriptase acts as a novel initiator of cartilage destruction via the induction and activation of matrix metalloproteinases (MMPs). Hepsin is another TTSP expressed in OA cartilage such that we hypothesized this proteinase may also contribute to matrix turnover. Herein, we demonstrate that addition of hepsin to OA cartilage in explant culture induced significant collagen and aggrecan release and activated proMMP-1 and proMMP-3. Furthermore, hepsin directly cleaved the aggrecan core protein at a novel cleavage site within the interglobular domain. Hepsin expression correlated with synovitis as well as tumour necrosis factor α expression, and was induced in cartilage by a pro-inflammatory stimulus. However, a major difference compared to matriptase was that hepsin demonstrated markedly reduced capacity to activate proteinase-activated receptor-2. Overall, our data suggest that hepsin, like matriptase, induces potent destruction of the extracellular matrix whilst displaying distinct efficiencies for the cleavage of specific substrates.

Citing Articles

Enhancement of adult liver regeneration in mice through the hepsin-mediated epidermal growth factor receptor signaling pathway.

Tsai Y, Fang M, Chen C, Yu I, Shun C, Tao M Commun Biol. 2024; 7(1):1672.

PMID: 39702454 PMC: 11659619. DOI: 10.1038/s42003-024-07357-1.


The DYRKP1 kinase regulates cell wall degradation in Chlamydomonas by inducing matrix metalloproteinase expression.

Kim M, Jorge G, Aschern M, Cuine S, Bertrand M, Mekhalfi M Plant Cell. 2024; .

PMID: 39401319 PMC: 11852342. DOI: 10.1093/plcell/koae271.


Type II Transmembrane Serine Proteases as Modulators in Adipose Tissue Phenotype and Function.

Wu Q, Li S, Zhang X, Dong N Biomedicines. 2023; 11(7).

PMID: 37509434 PMC: 10376093. DOI: 10.3390/biomedicines11071794.


Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells.

Rodenas M, Penas-Martinez J, Pardo-Sanchez I, Zaragoza-Huesca D, Ortega-Sabater C, Pena-Garcia J Front Mol Biosci. 2023; 10:1182925.

PMID: 37275957 PMC: 10235687. DOI: 10.3389/fmolb.2023.1182925.


Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients.

Zaragoza-Huesca D, Nieto-Olivares A, Garcia-Molina F, Ricote G, Montenegro S, Sanchez-Canovas M Cancers (Basel). 2022; 14(13).

PMID: 35804878 PMC: 9264764. DOI: 10.3390/cancers14133106.


References
1.
Beliveau F, Desilets A, Leduc R . Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides. FEBS J. 2009; 276(8):2213-26. DOI: 10.1111/j.1742-4658.2009.06950.x. View

2.
Barksby H, Milner J, Patterson A, Peake N, Hui W, Robson T . Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum. 2006; 54(10):3244-53. DOI: 10.1002/art.22167. View

3.
Kelso E, Ferrell W, Lockhart J, Elias-Jones I, Hembrough T, Dunning L . Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist. Arthritis Rheum. 2007; 56(3):765-71. DOI: 10.1002/art.22423. View

4.
Klezovitch O, Chevillet J, Mirosevich J, Roberts R, Matusik R, Vasioukhin V . Hepsin promotes prostate cancer progression and metastasis. Cancer Cell. 2004; 6(2):185-95. DOI: 10.1016/j.ccr.2004.07.008. View

5.
Xuan J, Schneider D, Toy P, Lin R, Newton A, Zhu Y . Antibodies neutralizing hepsin protease activity do not impact cell growth but inhibit invasion of prostate and ovarian tumor cells in culture. Cancer Res. 2006; 66(7):3611-9. DOI: 10.1158/0008-5472.CAN-05-2983. View